Chin Med Sci J September 2015
Vol. 30, No. 3 P. 189-192
CHINESE MEDICAL SCIENCES JOURNAL CASE REPORT
Postpartum Atypical Hemolytic Uremic Syndrome: an Unusual and Severe Complication Associated with IgA Nephropathy Li-xian Sun1, Wen-ling Ye2*, Yu-bing Wen2, and Xue-mei Li2 1
Department of Cardiology, 2Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
Key words: acute kidney injury; hemolytic uremic syndrome; IgA nephropathy; pregnancy Chin Med Sci J 2015; 30(3):189-192
I
GA nephropathy (IgAN) is one of the most common
medical history was negative before gestation.
types of primary glomerulonephritis, which occurs
Five days after cesarean section in the 40th gestational
more frequently in patients of reproductive age.
week, her urine volume started to decline, her blood
Atypical
pressure
hemolytic
uremic
syndrome
(aHUS)
increased
with
maximum
measurement at
without diarrhea is rare and has a poor prognosis. In the
180/110 mm Hg, and she developed progressive AKI. She
absence of appropriate therapy, pregnancy-related aHUS
had no fever, nor abnormality on neurological examinations.
is associated with high morbidity and mortality. This report
Her platelet count dropped to a minimum of 48×109/L, and
described a successfully treated case of postpartum aHUS
hemoglobin to 80 g/L with red blood cell fragmentation in
associated with IgAN. Repeated renal biopsy was per-
peripheral blood smears. Her urinary protein excretion was
formed to demonstrate serial renal pathologic changes
6.24 g/day. Serum biochemical parameters revealed low
after successful treatment.
albumin (18 g/L) and total protein (32 g/L) and elevated lactate dehydrogenase (1324 U/L). Her alanine amino-
CASE DESCRIPTION A 26-year-old female (gravida 1, para 1) presented with acute kidney injury (AKI), nephrotic syndrome,
transferase, aspartate aminotransferase, immunoglobulin and serum complement concentrations were normal. The detection for antinuclear antibodies (ANA), lupus anticoagulant and anticardiolipin antibody was negative.
thrombocytopenia and hemolytic anemia 5 days after
The diagnosis of HUS was made and she was treated
delivery. Routine urinalysis showed protein (1-2+) and
with intravenous methylprednisolone (60 mg/day) and
blood (2-3+) at the 22nd gestational week. Her blood
fresh frozen plasma infusion (400-600 ml/day) for 1 week,
pressure remained normal during the pregnancy, and her
followed by oral methylprednisolone [0.8 mg/(kg·d)]. Hemodialysis three times per week was initiated when her
Received for publication July 3, 2014.
serum creatinine was measured at 521 μmol/L one week
*Corresponding author Tel: 86-10-69155058, E-mail: wenlyepumch@
after delivery. Her platelet count gradually increased to
163.com
(80-100)×109/L and her blood pressure was controlled at
190
CHINESE MEDICAL SCIENCES JOURNAL
September 2015
lower than 140/90 mm Hg by angiotensin-converting enzyme
scribed with prednisone [1 mg/(kg⋅d)], which was decre-
inhibitors and angiotensin receptor blocker. A percutaneous
mented gradually after 6 weeks and maintained with the
renal biopsy was performed 2 weeks after delivery. Immuno-
dose of 5 mg/day for 1 year. She was also administered
fluorescence showed intense (3+) staining for IgA and C3
oral cyclophosphamide (100 mg/d) with cumulative dosage
in the mesangial area (Fig. 1A). Light microscopy displayed
of 9 grams. Her serum creatinine concentration decreased
severe mesangial proliferation and typical lesions of
to 110-120 μmol/L, and her 24-hour urinary protein was
thrombotic microangiopathy (TMA), including subendo-
less than 1 g in the follow-up visits after one year.
thelial mucosal edema, fibro-necrosis and marked thickening of the artery walls in the majority of afferent arterioles and
DISCUSSION
interlobular arteries (Fig. 1 B, C). The lumen of most arterioles was nearly completely occluded.
HUS, a form of TMA characterized by thrombocy-
Her renal function partially improved after 6 weeks of
topenia, hemolytic anemia and AKI, is a life-threatening
treatment, when hemodialysis and methylprednisolone
disorder presenting in 2.3%-9.1% of obstetric women with
were discontinued. She was referred to our hospital 7
AKI.1,2 In contrast to typical HUS, which is associated with
months after delivery because of sustained nephrotic-
diarrhea, aHUS, which occurs without diarrhea, is rare and
range proteinuria and renal dysfunction. Laboratory tests
has a poorer prognosis. It is usually secondary to autoim-
showed blood (3+) in urine, proteinuria of 3.21 g/24 h,
mune disease, malignant hypertension or medication.3
hemoglobin of 104 g/L, platelet count of 239×109/L, and
Pregnancy is also a risk factor for aHUS, with the highest
serum creatinine concentration of 143 μmol/L. Repeated
incidence near term and during the postpartum period.
renal biopsy showed moderate mesangial hypercellularity
This is also the time of greatest risk for thrombotic events
with segmental sclerosis and ischemic glomerular lesions
and for
(Fig. 1 D-F). Immunofluorescence findings were comparable
syndromes: preeclampsia, eclampsia, and hemolysis, elevated
with those observed during the first biopsy. She was pre-
liver enzymes, and low platelets (HELLP) syndrome.4
the
occurrence
of
other pregnancy-related
Figure 1. Serial renal pathologic changes 2 weeks and 7 months after delivery. A. Immunofluorescence showing diffuse and massive deposits of IgA in the mesangial area, confirming the diagnosis of IgA nephrology (×400). B. First renal biopsy performed 2 weeks postpartum, showing fibrinoid necrosis in the afferent arterioles. The glomerulus display severe mesangial proliferation and intracapillary thrombi (periodic acid-schiff stain, ×200). C. Renal biopsy at 2 weeks postpartum, showing severe mucosal edema with almost entirely occluded lumen in the interlobular (periodic acid-schiff stain, ×200). D-F. Renal biopsy taken 7 months after delivery, revealing moderate mesangial hypercellularity with mesangial expansion and segmental sclerosis (D, HE, ×200) and enlargement of the Bowman capsule (E, PASM, ×200). The vascular lumen of the interlobular arteries being re-canalized with mild intimal elastic membrane thickening (E&F, PASM, ×200).
Vol. 30, No.3
CHINESE MEDICAL SCIENCES JOURNAL
191
Although IgAN is one of the most common primary
this patient, may result in further injury of endothelial cells
glomerulonephritis, its diagnosis can only be confirmed by
of glomerular capillaries by the deposition of IgA immune
the immunolocalization of mesangial IgA deposition.
complexes at subendothelium, expansion of the mesangial
Pregnancy-related aHUS is quite rare in the setting of IgAN.
matrix, and mesangial cells proliferating into the subendo-
A search in Medline using the keywords “pregnancy”,
thelium.
“hemolytic uremic syndrome” and “IgAN” yielded no
Recently, genetic abnormalities of complement regulatory
articles published between 1966 and 2013. The incidence
genes are regarded as one of pathogenic mechanisms of
of aHUS associated with IgAN may be underestimated
aHUS.9,10 A review of 21 pregnant French women with
because some pregnant women with aHUS have no
aHUS found that 18 of them had complement abnormalities
opportunity to renal biopsy with the contraindication of severe
and 17 had dysregulation of alternative complement
illness or continuous thrombocytopenia. The strong depos-
regulatory proteins.10 However, the involvement of the
ition of IgA in mesangial areas and pathological findings
complement pathway in HUS development in this case is
typical of mesangial proliferation confirmed the diagnosis
uncertain, since her complement level was normal at the
of IgAN in this case. Routine examination during the
time of HUS diagnosis. Several mechanisms may contribute
pregnancy showed microhematuria and proteinuria without
to the association between aHUS and IgAN in this patient,
hypertension, which is the most common manifestation of
including hypercoagulable state and oxidative stress caused
IgAN, indicating that this patient had developed IgAN
by nephrotic syndrome, severe hypertension, mutations of
before aHUS.
genes encoding regulators of the alternative complement
Pregnancy-related HUS has a very poor prognosis, with a maternal mortality rate of 44% and a perinatal mortality 5
rate of 80%. Although the standard treatment of aHUS
pathway, and high coagulation activity related to pregnancy. However,
further
investigations
and
researches
are
requisite to explore the exact mechanisms of aHUS. In conclusion, although aHUS is rarely associated with
associated with IgAN is uncertain, early plasma exchange, are considered
IgAN, it should be considered in pregnant women with
effective and have been associated with a favorable
underlying glomerulonephritis when AKI occurs. Renal
outcome.6 Fortunately, the hemolytic anemia, thrombocy-
biopsies should be performed to exclude concomitant
topenia, and renal dysfunction in this case were rapidly
glomerulonephritis and titrate the appropriate therapy
ameliorated after plasma infusion, glucocorticoid therapy,
strategies for aHUS patients, especially in those with a
and hemodialysis. Sustained nephrotic-range proteinuria
history of microhematuria and proteinuria.
plasma
infusion, and glucocorticoids
and hypoalbuminemia, confirmed by repeated renal biopsy, was further improved after prescription of prednisone and
REFERENCES
cyclophosphamide and her renal dysfunction was gradually ameliorated.
1.
Silva GB Jr, Monteiro FA, Mota RM, et al. Acute kidney
The pathogenesis of postpartum aHUS occurring in
injury requiring dialysis in obstetric patients: a series of
IgAN is not well understood. Several causes or triggering
55 cases in Brazil. Arch Gynecol Obstet 2009; 279: 131-7.
factors may be involved in this process. Hypercoagulable
2.
Hassan I, Junejo AM, Dawani ML. Etiology and outcome of
state caused by nephrotic syndrome and pregnancy was
acute renal failure in pregnancy. J Coll Physicians Surg Pak
substantially considered to be an important risk factor for
2009; 19: 714-7.
aHUS. TMA was found to be associated with severe
3.
proteinuria in patients with IgAN.7 This patient presented with nephrotic syndrome with very severe hypoalbuminemia
Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011; 6:60.
4.
George JN. The association of pregnancy with thrombotic
(18 g/L) when HUS developed. Nephrotic syndrome may
thrombocytopenic purpura-hemolytic uremic syndrome.
contribute to thrombus formation in arterioles due to
Curr Opin Hematol 2003; 10: 339-44.
increased procoagulation factors, decreased anticoagulation
5.
proteins and fibrinolytic precursors.8 Pregnancy is also associated with increases in coagulation factor levels and
McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy. Semin Hematol 1997; 34: 148-58.
6.
Elliott MA, Nichols WL. Thrombotic thrombocytopenic
decrease in natural anticoagulation, leading to a hyper-
purpura and hemolytic uremic syndrome. Mayo Clin Proc
coagulable state with the greatest abnormalities at term
2001; 76: 1154-62.
and perinatal period. Thus, the combined effect of these
7.
Chang A, Kowalewska J, Smith KD, et al. A clinicopa-
two conditions leads to an increased tendency of thrombosis.
thologic study of thrombotic microangiopathy in the set-
In addition, severe mesangial proliferation of IgAN, as in
ting of IgA nephropathy. Clin Nephrol 2006; 66: 397-404.
192 8.
CHINESE MEDICAL SCIENCES JOURNAL Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboe-
9.
September 2015
Nephrol 2011; 43: 559-64. 10. Fakhouri F, Roumenina L, Provot F, et al. Pregnancy-
mbolic disease. Clin J Am Soc Nephro 2012; 7: 513-20.
associated hemolytic uremic syndrome revisited in the era
Leban N, Aloui S, Touati D, et al. Atypical hemolytic
of complement gene mutations. J Am Soc Nephrol 2010;
uremic syndrome in the Tunisian population. Int Urol
21: 859-67.
NOTICE OF RETRACTION The Editor retracts the following article from Chinese Medical Sciences Journal: Liu K, Hao J, Shi J, Dai C, Guo X. Blood Lead Levels During Pregnancy and Its Influencing Factors in Nanjing, China. Chin Med Sci J 2013; 28(2): 95-101. The first author, Kang-sheng Liu, admitted to the editors to flaws in data collection and analysis that affect the authenticity and accuracy of this article. Dr Liu takes full responsibility for this.